Health Care & Health-IT Under Obama


By Neil Versel, contributing editor

November 11, 2008 | WASHINGTON—The election of Barack Obama as president and the solidification of the Democratic majority in Congress clearly will have an effect on the national health care agenda for 2009, but some of the reasons might not be so obvious.

Something remarkable happened during the heated, seemingly interminable campaign that culminated Nov. 4: After Obama put forth a health care reform proposal, his opponent, Sen. John McCain (R-Ariz.) did more than simply pick apart the Obama plan. He issued a detailed plan of his own, something that does not always happen during a presidential race.

“It shows a coming of age of health care as an issue,” according to David Blumenthal, director of the Institute for Health Policy at Massachusetts General Hospital and Partners HealthCare System in Boston. Blumenthal, a longtime health-IT advocate, was a senior advisor on health care issues to the Obama campaign.

However, Blumenthal said here at the American Medical Informatics Association annual symposium that even though health care may have been the No. 2 concern among voters in exit polls, it trailed economic worries by nearly 6-to-1.

Of course, the weak economy, of course, stands to have a major effect on health policy in the near future. “The uninsured are likely to dominate the health care debate early in ’09,” said Washington lobbyist Douglas Peddicord, a member of the AMIA Public Policy Committee.

But so might the issue of privacy, which has held up many a health-IT bill in the past, and there is a good possibility Congress could seek to strengthen federal health privacy rules. “We are very much in HIPAA Round 2,” Peddicord said.

Much could depend on whether consumers start to embrace personal health records. PHRs, according to Peddicord, are “beginning to change the landscape” as a whole new constituency starts handling health care data. News like last week’s disclosure that pharmacy benefits manager Express Scripts was the target of an extortion attempt by someone who broke into the St. Louis-based company’s electronic patient files did nothing to soothe public jitters.

Obama has called for a five-year, $50 billion federal investment in health-IT to boost the move to electronic health records and construction of the National Health Information Network, but he recently said that stabilizing the economy and reforming the tax code would be his first priorities as president. To date, the president-elect has not indicated whom he might pick to lead the Department of Health and Human Services, much less the Centers for Medicare and Medicaid Services and other HHS agencies.

“The campaign is over,” Blumenthal said, “and campaigning and governing are two different modes.”

Two key federal health-IT advocates, Office of the National Coordinator for Health Information Technology leader Robert Kolodner, and Agency for Healthcare Research and Quality director Carolyn Clancy are career HHS employees, and could stay on in the new administration. 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.